pharmaceutical exports
India-Russia Trade Expansion: Seeking Approvals for Marine and Pharmaceutical Exports to Reach $100 Billion Goal by 2030
Nov 14, 2025 03:10 am CST
India seeks Russia's expedited approval for marine and pharmaceutical exports as part of strategic efforts to enhance bilateral trade from current $25 billion to $100 billion by 2030. Commerce Secretary Rajesh Agrawal's Moscow visit resulted in a comprehensive trade protocol covering multiple sectors including engineering, chemicals, electronics, and IT services, with both nations committing to explore payment solutions benefiting businesses of all sizes.
India's Exports to US Decline 37.5% Between May-September 2025: GTRI Analysis Reveals Sector-Wide Impact
Nov 03, 2025 02:21 am CST
A comprehensive analysis by the Global Trade Research Initiative (GTRI) reveals that India's exports to the United States have dropped by 37.5% between May and September 2025, falling from $8.8 billion to $5.5 billion. This significant decline affects multiple sectors including pharmaceuticals, textiles, metals, and solar panels, coinciding with the US implementation of 50% tariffs on various Indian products effective August 27.
Trump Administration Drops Plans to Impose Tariffs on Generic Drugs: A Positive Development for Indian Pharmaceutical Industry
Oct 10, 2025 06:25 pm CST
The Trump administration has decided against implementing tariffs on generic drugs imported from foreign countries, providing relief to both Indian pharmaceutical manufacturers, who supply nearly half of all generic prescriptions in the US market, and American consumers who depend on affordable medications. This decision comes after President Trump had previously announced 100 percent tariffs on branded drugs starting October 1.
Trump's 100% Pharmaceutical Tariffs: Global Impact on Countries and Companies
Sep 26, 2025 10:59 pm CST
President Trump's announcement of 100% tariffs on imported branded pharmaceuticals has sent shockwaves through the global drug industry. This policy, set to take effect in five days unless companies begin constructing US manufacturing facilities, threatens international pharmaceutical trade worth $252 billion annually. While the European Union claims protection through an existing trade agreement, countries like Switzerland and Denmark face significant risks. Pharmaceutical giants have already pledged $300 million in US investments as companies scramble to adapt to this protectionist measure that exempts generic medications but targets patented drugs.
Indian Generic Medicines Unaffected by Trump's 100% Pharmaceutical Import Tariff
Sep 26, 2025 05:57 pm CST
President Trump's new 100% tariff on pharmaceutical imports targets only patented and branded products, leaving Indian generic medicines unaffected according to the Indian Pharmaceutical Alliance. With Indian companies supplying 47% of US pharmaceutical needs and generating $219 billion in healthcare savings in 2022 alone, industry leaders remain confident in their market position as they continue providing affordable medications to American consumers.
Opinion | 6 Ways China Beat Trump At Trade Negotiations - And What India Can Learn
Jul 21, 2025 09:24 pm CST
As the US presses India with a "take-it-or-leave-it" offer, New Delhi must draw critical lessons from how China successfully negotiated with Washington in June 2025.